Rethinking Uncomplicated UTIs: A Comprehensive Review of Diagnosis, Management, and Novel and Emerging Treatment Options

UP TO 1.50 AMA PRA Credits
Overview
Learning Objectives
CME/ Information
Faculty and Disclosures

Program Overview

The high prevalence and significant personal and healthcare impact and the advancements in UTI management highlight the importance of accurate diagnosis, streamlined treatment protocols, and optimizing patient care.

HCPs must remain familiar with the classification of UTIs, the common signs and symptoms of uncomplicated UTIs, readily available diagnostic tools, and appropriate antibiotic selection based on local resistance patterns. Furthermore, staying updated on evolving antibiotic resistance trends and the potential need for alternative therapies is crucial.

Effective management also requires clear communication and collaboration within healthcare teams to ensure optimal patient outcomes. This includes providing standardized education and support for patients to understand their condition, treatment options, and preventative measures.

By focusing on these collective efforts, we can ensure the best possible care for patients with uncomplicated UTIs and minimize the risk of complications. 

This immersive, AI Patient Simulation will explore these facets of care, while allowing learners to put their knowledge into practice by engaging with an AI patient. 

Target Audience

This educational initiative is designed for primary care physicians, physician assistants, nurse practitioners, nurses and other healthcare professionals in primary care.  

Supporter Acknowledgement

This educational activity is supported by an independent educational grant from GSK.

Learning Objectives

Upon completion of this activity, the participant should be able to:
  • APPLY evidence-based guidelines to accurately interpret signs, symptoms, and laboratory test results for diagnosing uUTIs. 
  • UTILIZE evidence-based guidelines in selecting antimicrobial therapy for uncomplicated UTIs, thereby minimizing unnecessary antibiotic use. 
  • REVIEW the key factors contributing to treatment failure in patients with uncomplicated urinary tract infections. 
  • EVALUATE the impact of uUTI and treatment failure on patient well-being. 
  • INTEGRATE patient education and shared decision-making into their management of uUTIs,. 

Accredited Provider

This activity is jointly provided by Global Education Group and Iridium Continuing Education.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.5 contact hours including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Iridium CE do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.

Disclosures of Relevant Financial Relationship(s)

​Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:
Matt T. Rosenberg, MD
Director, Mid Michigan Health Centers
Jackson, MI

Disclosures
Nothing to disclose

Jennifer Anger,
MD, MPH 
Professor and Vice Chair of Research
C. Lowell and JoEllen Parsons Endowed Chair in Urology
Diplomate, American Board of Urology
Gender Affirming Surgery, Urologic Reconstruction and FPMRS
UC San Diego Department of Urology

Disclosures
Nothing to disclose
Loren Miller,
MD, MPH
Professor of Medicine
David Geffen School of Medicine at UCLA
Chief, Division of Infectious Diseases
Harbor-UCLA Medical Center

Disclosures
Nothing to disclose
Richard Colgan,
MD,
Professor Emeritus Department of Family and Community Medicine University of Maryland School of Medicine
Annapolis, MD

Disclosures
Nothing to disclose
Melissa Kaufman,
MD, PhD
Patricia and Rodes Hart Endowed Chair in Urologic Surgery
Professor of Urology
Chief, Division of Reconstructive Urology and Pelvic Health
Vanderbilt University Medical Center

Disclosures
Nothing to disclose.
This educational activity is supported by an independent educational grant from GSK.

Maximum Credit Amount: 1.50

Credit Type: ACCME, ANCC
Release: 03/31/2025
Expiration: 03/31/2026